| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax – What did we find in 10 years of clinical evidence?
|
Dias, E.
|
|
|
27 |
1 |
p. 80-81
|
article
|
| 2 |
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask
|
Crimi, Claudia
|
|
|
27 |
1 |
p. 1-3
|
article
|
| 3 |
COVID-19 effects on tuberculosis care in Sierra Leone
|
Buonsenso, D.
|
|
|
27 |
1 |
p. 67-69
|
article
|
| 4 |
Extracorporeal membranous oxygenation for a severe case of vaping associated lung injury
|
Regmi, M.R.
|
|
|
27 |
1 |
p. 69-70
|
article
|
| 5 |
First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient
|
Pecho-Silva, S.
|
|
|
27 |
1 |
p. 77-79
|
article
|
| 6 |
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
|
Kow, C.S.
|
|
|
27 |
1 |
p. 86-87
|
article
|
| 7 |
Low dose computed tomography of the lung for detection and grading of interstitial lung disease: A systematic simulation study
|
Ley, S.
|
|
|
27 |
1 |
p. 14-25
|
article
|
| 8 |
Pneumonia mortality, comorbidities matter? Authors’ answer
|
Hespanhol, V.
|
|
|
27 |
1 |
p. 85-86
|
article
|
| 9 |
Potential survival paradox in pneumonia
|
Ito, H.
|
|
|
27 |
1 |
p. 84
|
article
|
| 10 |
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
|
Cortegiani, A.
|
|
|
27 |
1 |
p. 52-66
|
article
|
| 11 |
Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply
|
Cortegiani, A.
|
|
|
27 |
1 |
p. 87-88
|
article
|
| 12 |
Rhodococcus equi infection as inaugural manifestation of idiopathic CD4+ lymphopenia: A rare entity and a therapeutic challenge
|
Alves, A.
|
|
|
27 |
1 |
p. 75-77
|
article
|
| 13 |
Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room
|
Singla, R.
|
|
|
27 |
1 |
p. 35-42
|
article
|
| 14 |
Secondary pulmonary alveolar proteinosis in a patient with systemic lupus erythematosus
|
Yamasaki, M.
|
|
|
27 |
1 |
p. 81-83
|
article
|
| 15 |
Spontaneous pneumomediastinum: Beyond the risky diving
|
Juanola-Pla, Jordi
|
|
|
27 |
1 |
p. 88-89
|
article
|
| 16 |
The “Big Five” Lung Diseases in CoViD-19 Pandemic – a Google Trends analysis
|
Barbosa, M.T.
|
|
|
27 |
1 |
p. 71-72
|
article
|
| 17 |
The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer
|
Sakin, A.
|
|
|
27 |
1 |
p. 26-34
|
article
|
| 18 |
The role of non-invasive ventilation in weaning and decannulating critically ill patients with tracheostomy: A narrative review of the literature
|
Guia, Miguel
|
|
|
27 |
1 |
p. 43-51
|
article
|
| 19 |
Total volume/week of physical activity: an underused variable of physical activity in daily life in patients with copd and its association with exercise capacity
|
Schneider, Lorena P.
|
|
|
27 |
1 |
p. 73-75
|
article
|
| 20 |
Translating Idiopathic pulmonary fibrosis guidelines into clinical practice
|
Robalo-Cordeiro, C.
|
|
|
27 |
1 |
p. 7-13
|
article
|
| 21 |
Tuberculosis — Reaping benefits from COVID-19 in Portugal
|
Mateiro Gomes, B.L.
|
|
|
27 |
1 |
p. 4-6
|
article
|
| 22 |
Wearing masks and the fight against the novel coronavirus (COVID-19)
|
Alizargar, Javad
|
|
|
27 |
1 |
p. 89
|
article
|
Journal description